Meeting
2023 ASCO Annual Meeting
Association of minimizing the false negative rate of axillary staging surgery in patients with cN1 breast cancer after neoadjuvant chemotherapy with surgical overtreatment.
Authors
Alison Laws
Dana-Farber Brigham Cancer Center, Boston, MA
Alison Laws , Saskia Leonard , Julie Vincuilla , Tonia Parker , Olga Kantor , Elizabeth A. Mittendorf , Anna Weiss , Tari A. King
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Local-Regional Therapy
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 587)
DOI
10.1200/JCO.2023.41.16_suppl.587
Abstract #
587
Poster Bd #
417
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
First Author: Maggie Banys-Paluchowski
Poster
2023 ASCO Breakthrough
Risk assessment, prevention and early detection of breast cancer related lymphedema: Objective measurements and patient reported outcomes.
First Author: Anshumi Desai
Poster
2018 ASCO Annual Meeting
Impact of residual nodal disease burden on sentinel node mapping and accuracy of intraoperative frozen section in node positive (cN1) breast cancer patients treated with neoadjuvant chemotherapy (NAC).
First Author: Alison Laws
Poster
2011 Breast Cancer Symposium
Axillary node staging for microinvasive breast cancer: Is it justified?
First Author: J. M. Lyons III